D32.9
BillableBenign neoplasm of meninges, unspecified
Last updated: FY2026 ICD-10-CM (Oct 1, 2025 – Sep 30, 2026) | CMS-HCC V28 (100% phase-in, PY2026)
Is D32.9 an HCC code?
Yes. D32.9 maps to Melanoma and Other Skin Cancers under the CMS-HCC V28 risk adjustment model (and Breast, Prostate, and Other Cancers and Tumors under V24).
HCC Category Mapping
RAF weights shown are the community, non-dual, aged base weights from the CMS risk adjustment model file. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.
MEAT Criteria for D32.9
For D32.9 to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically — it has to be re-documented and supported each calendar year.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed D32.9 during that encounter — not just copy-forwarded from a problem list.
What This Code Means
D32.9 is the ICD-10-CM diagnosis code for benign neoplasm of meninges, unspecified. A non-cancerous tumor of the brain or spinal cord protective membranes when the specific location is not documented. D32.9 sits in the ICD-10-CM chapter for neoplasms (c00-d49), within the section covering benign neoplasms, except benign neuroendocrine tumors (d10-d36).
Under the CMS-HCC V28 risk adjustment model, D32.9 maps to Melanoma and Other Skin Cancers (HCC 23) with a community, non-dual, aged base RAF weight of 0.251. Under the older CMS-HCC V24 model, D32.9 maps to Breast, Prostate, and Other Cancers and Tumors (HCC 12) with a community, non-dual, aged base RAF weight of 0.150. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.
Use this code only when the specific site of the meningeal neoplasm cannot be determined. Because D32.9 maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.
HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for D32.9 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •Use this code only when the specific site of the meningeal neoplasm cannot be determined
- •Query the provider if possible to obtain more specific anatomical location for accurate coding
Clinical Significance
Benign neoplasm of the meninges, unspecified, captures meningiomas or other benign meningeal tumors where the specific location (cerebral vs. spinal) has not been documented. Meningiomas are the most common primary intracranial tumors and are overwhelmingly benign (WHO Grade I). This code should be temporary, used until imaging or pathology clarifies the specific location.
Documentation Requirements
- ✓At minimum, imaging evidence or pathologic confirmation of a benign meningeal neoplasm is needed. Every effort should be made to document whether the tumor is intracranial (cerebral) or intraspinal to allow assignment of D32.0 or D32.
- ✓Query the provider when the site is not specified in the documentation.
Commonly Confused Codes
- •D32.0 (cerebral meninges) is preferred when the intracranial location is documented
- •D32.1 (spinal meninges) is for spinal meningiomas
- •D42.9 (neoplasm of uncertain behavior of meninges, unspecified) is for atypical WHO Grade II tumors
- •D33.9 (benign neoplasm of CNS, unspecified) covers broader CNS locations.